Department of Nephrology, People's Hospital of Jianyang, Chengdu, 641400, Sichuan, China.
Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, 37th Guoxuexiang Road, Chengdu, 610041, Sichuan, China.
Int Urol Nephrol. 2021 Feb;53(2):315-323. doi: 10.1007/s11255-020-02631-7. Epub 2020 Sep 17.
The aim of this study was to explore the effect of sex on the clinicopathological features and long-term outcomes of IgAN patients.
A total of 1096 adult IgAN patients were divided into male and female groups. Clinicopathological features and risk factors of IgAN patients of different genders were contrasted. The primary endpoint was the combined endpoint of a 50% reduction in estimated glomerular filtration rate (eGFR) and/or end stage renal disease (ESRD: eGFR < 15 mL/min/1.73 m or dialysis). The effect of gender on prognosis of IgAN was assessed using Kaplan-Meier and Cox proportional hazards models.
In total, 475 male patients and 621 female patients were included in this study. At baseline, male patients had higher values for blood pressure, serum creatinine, urine protein and serum uric acid, as well as lower levels of eGFR. Further analysis indicated that tubular atrophy/interstitial fibrosis (T) lesions and vascular lesions were more frequent in male patients. During the follow-up period of 40.9 ± 24.2 months, kidney survival rates of male IgAN patients were remarkably lower than those of female patients. Using multivariate Cox regression analysis, male gender was identified as an independent risk factor for poor outcomes (β = 0.384, Wald = 4.290, Exp (β) = 1.47, p = 0.038), including hypertension, low eGFR, IgM deposition, arteriosclerosis lesions and T1-T2 lesions. However, male and female patients were characterized by different risk factors.
Male patients presented with more severe clinical and pathological changes than female patients. Renal survival rates of male patients were remarkably lower than those of female patients, and male gender was identified as an independent risk factor for poor outcomes.
本研究旨在探讨性别对 IgA 肾病患者临床病理特征和长期预后的影响。
共纳入 1096 例成人 IgA 肾病患者,分为男性组和女性组。对比不同性别 IgA 肾病患者的临床病理特征及危险因素。主要终点为肾小球滤过率(eGFR)下降 50%及/或终末期肾病(eGFR<15 mL/min/1.73 m 或透析)复合终点。采用 Kaplan-Meier 生存分析和 Cox 比例风险回归模型评估性别对 IgA 肾病预后的影响。
共纳入 475 例男性患者和 621 例女性患者。基线时,男性患者的血压、血肌酐、尿蛋白、血尿酸较高,eGFR 较低。进一步分析显示,男性患者的肾小管萎缩/间质纤维化(T)病变和血管病变更为常见。随访 40.9±24.2 个月期间,男性 IgA 肾病患者的肾脏生存率显著低于女性患者。多因素 Cox 回归分析显示,男性为不良预后的独立危险因素(β=0.384,Wald=4.290,Exp(β)=1.47,p=0.038),包括高血压、低 eGFR、IgM 沉积、动脉硬化病变和 T1-T2 病变。然而,男性和女性患者的危险因素不同。
男性患者的临床和病理变化较女性患者更为严重。男性患者的肾脏生存率显著低于女性患者,且男性为不良预后的独立危险因素。